Screener
Vir Biotechnology, Inc. VIR Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Vir Biotechnology, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:20 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053549
FAQ
- What is Vir Biotechnology, Inc.'s accounts payable?
- Vir Biotechnology, Inc. (VIR) reported accounts payable of $17.75M in Q2 2026.
- How has Vir Biotechnology, Inc.'s accounts payable changed year-over-year?
- Vir Biotechnology, Inc.'s accounts payable increased by 45.1% year-over-year, from $12.23M to $17.75M.
- What is the long-term trend for Vir Biotechnology, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s accounts payable has grown at a 14.1% compound annual growth rate (CAGR), from $5.08M to $9.8M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Vir Biotechnology, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude